Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Daniel Sherbenou

Concepts (177)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Daniel Sherbenou's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Daniel Sherbenou has written about over time.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 5 publications between 2005 and 2010, average publication date October 2007. Piperazines, 5 publications between 2005 and 2010, average publication date October 2007. Pyrimidines, 5 publications between 2005 and 2010, average publication date October 2007. Fusion Proteins, bcr-abl, 4 publications between 2007 and 2010, average publication date April 2008. Protein Kinase Inhibitors, 6 publications between 2005 and 2019, average publication date October 2009. Drug Resistance, Neoplasm, 6 publications between 2005 and 2020, average publication date December 2009. Immunoconjugates, 3 publications between 2014 and 2020, average publication date June 2017. Antibodies, Neoplasm, 2 publications between 2016 and 2018, average publication date October 2017. Membrane Cofactor Protein, 2 publications between 2016 and 2018, average publication date October 2017. Antibodies, Monoclonal, 8 publications between 2014 and 2023, average publication date July 2019. Hematopoietic Stem Cell Transplantation, 3 publications between 2017 and 2021, average publication date August 2019. Multiple Myeloma, 15 publications between 2014 and 2024, average publication date November 2019. Antineoplastic Combined Chemotherapy Protocols, 6 publications between 2017 and 2023, average publication date May 2020. Protein Biosynthesis, 1 publications between 2020 and 2020, average publication date October 2020. Protein Synthesis Inhibitors, 1 publications between 2020 and 2020, average publication date October 2020. Hydrazines, 1 publications between 2021 and 2021, average publication date March 2021. Triazoles, 1 publications between 2021 and 2021, average publication date March 2021. Neoplasm Recurrence, Local, 3 publications between 2020 and 2023, average publication date October 2021. Intercellular Adhesion Molecule-1, 2 publications between 2020 and 2024, average publication date May 2022.

To see the data from this visualization as text, click here.
Sherbenou's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)